This corrects the article DOI: 10.1038/nature04585.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1038/nature23287 | DOI Listing |
Cell Oncol (Dordr)
January 2025
Department of Oncogene Regulation, Chittaranjan National Cancer Institute, 37, S.P. Mukherjee Road, Kolkata, West Bengal, 700026, India.
Biomed Pharmacother
January 2025
Department of Pathology, Affiliated Hospital of Jining Medical University, Jining, Shandong 272029, China. Electronic address:
CK-666, an inhibitor of the actin-related protein complex 2/3 (Arp2/3), can suppress lamellipodia formation and cell migration. However, research on its application in tumor therapy is still limited. Using RNA-seq, we clustered and analyzed the functions of differentially expressed mRNAs in CK-666-treated tumor cells.
View Article and Find Full Text PDFOncogene
January 2025
Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, 27157, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!